Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical Usefulness of 8-F Sheathless Guiding Catheter for Transradial Approach in Complex Percutaneous Coronary Intervention.

Created on 08 Jul 2026

Authors

Hiroaki Matsuda, Satoru Tohara, Takeshi Niizeki, Kenichiro Shimoji, Shingo Hosogi, Kazuhiro Ashida, Etsuo Tsuchikane

Published in

JACC. Asia. Volume 6. Issue 7. Pages 1294-1298.

Abstract

This study evaluated the safety and efficacy of complex transradial coronary intervention (TRI) with an 8-F sheathless guiding catheter (GC).We enrolled 106 consecutive patients who underwent complex transradial coronary intervention (TRI) using 8-F sheathless GC at multiple centers between August 2021 and December 2022 and assessed the clinical effects and incidence rates of early radial artery occlusion (RAO) after the TRI. Ultrasound assessment for the target radial access was performed both before (following administration of nicorandil) and after the procedure. All patients successfully underwent the TRI. Among the patients, 3 (3.1%) developed RAO the day after the procedure, whereas 7 (6.6%) developed RAO within 3 months. Nicorandil administration significantly increased the inner diameter of the radial artery (before: 2.80 ± 0.49 mm, after: 3.00 ± 0.56 mm). TRI with an 8-F sheathless GC might be effective for patients with high bleeding risk who require complex percutaneous coronary intervention procedures.

PMID:
42412710
Bibliographic data and abstract were imported from PubMed on 08 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement